ConTIPI medical develops unique non-invasive and disposable vaginal devices for women with pelvic floor disorders
ConTIPI Medical’s devices are inserted into the vagina in small dimensions, within an applicator, by the user herself, and removed in small dimensions by a pull of a string
ConTIPI Medical’s products empower women and convey important social messages – freedom to decide, and shift of control.

The Future Is Here

ConTIPI Medical provides cutting edge non-surgical and disposable vaginal solutions for women with various Pelvic Floor Disorders (PFD’s). These solutions are all vaginal devices which follow a cutting edge concept. They all come ready for use, inserted vaginally in small dimensions inside an applicator. Within the vagina they open and provide support to predefined specific sites along vaginal walls. By the end of usage, devices are removed by a pull of a string, which also causes them to considerably diminish in size, for disposal. Previous device, for the management of Stress Urinary Incontinence (SUI), was sold to Kimberly Clark Worldwide Inc, and is marketed under its Poise® brand (https://www.impressapro.com). ConTIPI Medical’s ProVate Device, for the non-surgical management of Pelvic Organ Prolapse (POP) has a 510(k) clearance from FDA for marketing in the United States, and a CE Mark for marketing in the EU.

Our Capabilities

null

Medical knowledge by experienced urogynecologist

null

strategies are backed by well recognized business experts

null

Extensive and strong Intellectual Property

null

Creative R&D team

null

Idea conception and brainstorming are done internally

null

Regulatory affairs are managed in-house

null

Experience in conducting clinical studies from early stages

null

In-house production and assembly abilities

Our Innovative Solutions

Products
null

ProVate Device

Most women with Pelvic Organ Prolapse will only require non-invasive management. Existing pessaries are associated with high discontinuation rate, and with high rate of reluctance to use a reusable device which is difficult for most users to insert and remove. This disposable device was designed to provide vaginal support, inserted and removed by the user at her home.

READ MORE
null

Impressa Device

The Impressa device was invented by a urogynecologist in order to bridge the large gap between non-invasive and invasive treatments for Stress Urinary Incontinence in women. The device was designed to be a user friendly disposable vaginal support, available to many women, including those who do not wish to disclose their intimate problem.

READ MORE

From The Company

Management meeting at ConTIPI Medical

Declaration of Independence – freedom to manage your POP

Prototype device assembly within ConTIPI Medical’s clean rooms

ProVate Device – state of the art product to support modern women in challenging modern society

Research & Development (R&D) lab at ConTIPI Medical. Various tests are done to ensure compliance with strict regulatory requirements.

Disruptive Innovations in Feminine care

Dr Elan Ziv, ConTIPI Medical’s CEO, during an interview by Kathy Ireland for her show Modern Living

Independent prolapse control

POP In The US

0
Women with POP
0
women consult on POP with their doctor
0
women are eventually treated for POP

The Management

Dr. Elan Ziv
CEO & Medical Director
MD, OBGYN, FPMRS
Meital Vaknin-Shimony
VP Operations
B.Sc., MBA
Zohar Tyroler
VP Research & Development
B.Sc., MBA
Indegene and ConTIPI Medical Ltd partner to bring innovative disposable non-surgical device to market to help women suffering from Pelvic Organ Prolapse (POP)
Please leave your massage
Investors - Please Contact
Most women with Pelvic Organ Prolapse will only require non-invasive management. Existing pessaries are associated with high discontinuation rate, and with high rate of reluctance to use a reusable device which is difficult for most users to insert and remove. This disposable device was designed to provide vaginal support, inserted and removed by the user at her home.
Read More
Product and company information
Partnership Page
Skip to content